lymphoid leukemia

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

Not yet recruiting
  • Breast Cancer
  • +9 more
  • Assessment tool IA3-CP with SDoH
  • Assessment tool IA3-CP without SDoH
  • (no location specified)
May 22, 2023

Pediatric and Young Adult B-Cell Malignancies After Commercially

Not yet recruiting
  • Lymphoid Leukemia
  • Questionnaire for patients receiving therapy
  • Palo Alto, California
    Stanford University
May 9, 2023

Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

Completed
  • Lymphoid Leukemia
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Jan 30, 2023

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

Not yet recruiting
  • Lymphoid Leukemia
  • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
  • Treg CD34+ HSPC (Orca-T)
  • Palo Alto, California
    Stanford Cancer Center
Aug 17, 2022

Bone and Joints, Brain and Nervous System, Leukemia, NOS Trial in San Francisco (GOLD Program, Treatment as usual (TAU))

Recruiting
  • Bone and Joints
  • +4 more
  • GOLD Program
  • Treatment as usual (TAU)
  • San Francisco, California
    Stanford Cancer Institute
Jun 8, 2022

Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)

Active, not recruiting
  • Hodgkin Lymphoma
  • +6 more
  • Intravenous (IV) and oral Vitamin C
  • Richmond, Virginia
    Virginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Healthy Bones, Healthy Life

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • +12 more
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Dec 10, 2021

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

    Terminated
    • Non-Hodgkin's Lymphoma
    • +5 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Dec 14, 2020

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Plasma Cell Myeloma Trial in Madison (Behavioral techniques)

    Completed
    • Hodgkin Lymphoma
    • +6 more
    • Behavioral techniques
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Nov 13, 2019

    Hodgkin's Lymphoma, Leukemia, Lymphoid Leukemia Trial in Madison (Behavioral techniques)

    Completed
    • Hodgkin's Lymphoma
    • +6 more
    • Behavioral techniques
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Nov 14, 2019

    Acute Myeloid Leukemia, Lymphoid Leukemia Trial (Oshadi D & Oshadi R;, salvage therapy cytosar and mitoxantrone)

    Suspended
    • Acute Myeloid Leukemia
    • Lymphoid Leukemia
    • Oshadi D & Oshadi R;
    • salvage therapy cytosar and mitoxantrone
    • (no location specified)
    Apr 16, 2018

    Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem

    Completed
    • Acute Myelogenous Leukemia
    • +8 more
    • Chicago, Illinois
      The University of Chicago
    Oct 7, 2016

    Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia Trial in Worldwide (StemEx®)

    Completed
    • Hematologic Malignancies
    • +6 more
    • Los Angeles, California
    • +29 more
    Jul 9, 2015

    Lymphoid Leukemia Trial in Bologna (doxorubicin liposomal)

    Unknown status
    • Lymphoid Leukemia
    • doxorubicin liposomal
    • Bologna, Italy
      Institute of Hematology "L. & A. Seragnoli"
    Sep 14, 2009